Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

West Pharmaceutical Services, Inc. Common Stock (NY:WST)

219.97 -1.53 (-0.69%)
Official Closing Price Updated: 7:00 PM EDT, Apr 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about West Pharmaceutical Services, Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
$100 Invested In West Pharmaceutical Servs 15 Years Ago Would Be Worth This Much Today
Via Benzinga
Why NYSE:WST qualifies as a quality stock.
WEST PHARMACEUTICAL SERVICES (NYSE:WST) may be suited for quality investing, we'll explore why in this article. 
Via Chartmill
West Pharmaceutical Services Inc. (NYSE: WST) Sets New 52-Week High in Tuesday Session
Via Investor Brand Network
How Is The Market Feeling About West Pharmaceutical Servs?
Via Benzinga
A Look Into West Pharmaceutical Servs Inc's Price Over Earnings
Via Benzinga
Here's How Much You Would Have Made Owning West Pharmaceutical Servs Stock In The Last 15 Years
Via Benzinga
Worried About Market Froth? Buy These 3 Dividend Stocks
If you are concerned about the massive rallies in tech leading to sharp corrections, then taking profits or adding other positions could be a prudent move. One place to look for solace when the broader... 
Via Talk Markets
West Pharmaceutical Servs: Dividend Insights
Via Benzinga
How Is The Market Feeling About West Pharmaceutical Servs?
Via Benzinga
$1000 Invested In West Pharmaceutical Servs 20 Years Ago Would Be Worth This Much Today
Via Benzinga
P/E Ratio Insights for West Pharmaceutical Servs
Via Benzinga
10 Safest Dividend Aristocrats For 2023
A company cannot pay rising dividends for 25+ years without having a strong and durable competitive advantage. But some Dividend Aristocrats are better than others, based on the sustainability of their... 
Via Talk Markets
$1000 Invested In This Stock 20 Years Ago Would Be Worth $62,000 Today
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 16, 2023
Via Benzinga
NVIDIA To Rally Over 17%? Here Are 10 Other Analyst Forecasts For Friday
Raymond James boosted the price target for Jabil Inc. (NYSE: JBL) from $100 to $120. Raymond James analyst Melissa Fairbanks maintained a Strong Buy rating. Jabil shares rose 5% to close at $104.64 on... 
Via Benzinga
Here's How Much You Would Have Made Owning West Pharmaceutical Servs Stock In The Last 15 Years
Via Benzinga
Here's How Much You Would Have Made Owning West Pharmaceutical Servs Stock In The Last 15 Years
Via Benzinga
3 ETFs to Buy for Stress-Free Profits
These stress-free ETFs won't fluctuate a great deal and can be relied upon to deliver profits in the medium-term and the long-term. 
Via InvestorPlace
$1000 Invested In This Stock 5 Years Ago Would Be Worth $4,000 Today
Via Benzinga
3 Overvalued S&P 500 Stocks to Dump Now
Investors should consider taking profits on these overvalued S&P 500 stocks now with a potential recession on the horizon. 
Via InvestorPlace
7 Dividend Aristocrats to Buy for Long-Term Income
These dividend aristocrats are the best stocks to buy for long-term income generation and lower portfolio risk. 
Via InvestorPlace
Analyst Says West Pharmaceutical Services Is 'Expensive But For Good Reason'
Via Benzinga
$100 Invested In West Pharmaceutical Servs 5 Years Ago Would Be Worth This Much Today
Via Benzinga
$1000 Invested In This Stock 5 Years Ago Would Be Worth $4,000 Today
Via Benzinga
Earnings Scheduled For April 27, 2023
Companies Reporting Before The Bell • Cazoo Gr (NYSE:CZOO) is expected to report earnings for its first quarter. 
Via Benzinga
Here's How Much You Would Have Made Owning West Pharmaceutical Servs Stock In The Last 5 Years
Via Benzinga
West Pharmaceutical Servs: Dividend Insights
Via Benzinga
West Pharmaceutical Servs Earnings Conference Call Is Coming Up, Here's What You Need To Know
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 11, 2023
Via Benzinga
What Factors Will Drive S&P 500 Performance This Year?
Analysts are forecasting a positive return for the S&P 500, and back-to-back downside years are rare. But weakening earnings could put a dent in returns. 
Via MarketBeat
Topics ETFs Stocks
Exposures US Equities
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.